Imaging: Mass spectrometry in HNSCC--a peek at response prediction? [electronic resource]
- Nature reviews. Clinical oncology Apr 2010
- 193-5 p. digital
Publication Type: Journal Article
1759-4782
10.1038/nrclinonc.2010.35 doi
Algorithms Antineoplastic Agents--therapeutic use Biomarkers, Tumor Carcinoma, Squamous Cell--drug therapy ErbB Receptors--antagonists & inhibitors Head and Neck Neoplasms--drug therapy Humans Mass Spectrometry Prognosis Risk Factors Survival Analysis United States